Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia
Clinical trial NCT01900522 · TERMINATED
Trial details
- NCT number
- NCT01900522
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-09-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.